Stock Watch: Amarin And Esperion Cut Sales And Marketing Costs
When Sales Decline Or Launches Falter, Marketing Costs Are The First Target
Executive Summary
Unlike big pharma, some small commercial companies cut sales and marketing costs in 2021. But with a little imagination, it could go further.